Impact of the Initial Influenza Exposure on the Quality, Magnitude, Breadth, Potency and Durability of Influenza Immunity
初次接触流感对流感免疫的质量、程度、广度、效力和持久性的影响
基本信息
- 批准号:9925182
- 负责人:
- 金额:$ 438.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-05-15 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAntibodiesAntigensB-LymphocytesBloodBreast FeedingChildChildhoodCitiesClinicalCollectionEffectivenessElderlyEnrollmentEpitopesEvaluationExposure toFrequenciesFutureGenetic ProgrammingGenetic VariationGoalsHumanImmuneImmune responseImmunityImmunizationImmunologic MemoryImmunologicsImmunologyIndividualInfantInfectionInfectious Disease EpidemiologyInfluenzaInfluenza A virusInfluenza vaccinationInfrastructureInstructionKnowledgeLifeMaintenanceMemoryMexicoMilkMothersNatureNosePediatric HospitalsPopulationPredispositionPregnant WomenPrimary InfectionReportingResearch PersonnelSamplingScheduleShapesSiteSwabSymptomsT memory cellT-LymphocyteUmbilical Cord BloodVaccinationVaccinesVariantViralViral AntigensVirusVirus Diseasescohortimprintimprovedinfancyinfluenza virus straininfluenza virus vaccineinfluenzaviruspostnatalrecruitresponseseasonal influenzasecondary infectionstemuniversal influenza vaccineuniversal vaccinevirologyvirus genetics
项目摘要
PROJECT SUMMARY ABSTRACT
A more universal vaccine against influenza virus infection is urgently needed. However, a major obstacle
limiting more effective and durable vaccines against influenza infection stem from the rapidly shifting nature of
viral immune dominant epitopes. Further confounding this obstacle are functional differences in the
immunological responsiveness to vaccination and susceptibility of individuals to natural infection primed by
prior exposure to influenza antigens. This type of immunological imprinting likely explains the wide discordance
in effectiveness of current seasonal influenza vaccines. Considering the near ubiquitous exposure of
individuals to influenza virus, together with the wide variability in clinical symptoms from asymptomatic to
severe infection and increasingly widespread use of seasonal immunization, immunological imprinting to
influenza virus is likely initiated during infancy with the first exposure to natural infection or immunization.
Importantly, critical knowledge gaps remain regarding how individuals respond to primary influenza exposure in
early life, in the context of natural infection or vaccination, and how a lack of pre-existing immunity effects
within-host influenza viral diversity. It is also unclear how this first exposure to influenza impacts the
subsequent immunological responsiveness to antigenically identical, similar or discordant influenza epitopes.
For infants, the impact of vertically transferred maternal immunity, or that acquired postnatally through
breastfeeding, on the quality of ensuing influenza specific immune responses remain unclear. To fill these
knowledge gaps, ongoing recruitment of a maternal-infant cohort at Cincinnati Children’s Hospital will be
expanded, along with parallel efforts in Mexico City. Both sites have ongoing surveillance providing additional
cases of symptomatic primary infection. With the proposed enrollment of more than 2000 pregnant women, our
two-site cohort is ideally suited for the proposed studies given our established infrastructure of weekly nasal
swabs and symptom reporting, scheduled blood collection to detect asymptomatic and symptomatic influenza,
maternal and cord blood and milk sample analyses and detailed evaluations of susceptibility and
immunological responses to influenza infection and vaccination in mothers and infants. Our overall hypothesis
is that primary influenza exposure in early life impacts the magnitude, durability and breadth of immunological
memory to an evolving range of influenza virus antigens and this initial imprint will have a profound effect on
subsequent influenza exposures. A team of investigators with complementary expertise in pediatric infectious
diseases, epidemiology, maternal-infant cohorts, human B and T cell immunology and influenza virology have
been assembled to address our hypothesis by investigating the immunological response of infants to primary
influenza virus natural infection compared with immunization (Aim 1), compare the immunological response
against an initial exposure to influenza virus via natural infection or immunization in infants (Aim 2), and
investigating the impact of pre-existing influenza immunity on virus genetic diversity within individuals (Aim 3).
项目摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARY A STAAT其他文献
MARY A STAAT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARY A STAAT', 18)}}的其他基金
US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children
美国加强监测网络评估疫苗预防儿童肠道和呼吸道病毒的负担、自然史和有效性
- 批准号:
10347720 - 财政年份:2021
- 资助金额:
$ 438.7万 - 项目类别:
US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children
美国加强监测网络评估疫苗预防儿童肠道和呼吸道病毒的负担、自然史和有效性
- 批准号:
10598645 - 财政年份:2021
- 资助金额:
$ 438.7万 - 项目类别:
IP21-002 US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children
IP21-002 美国增强监测网络,评估预防儿童肠道和呼吸道病毒的疫苗负担、自然史和有效性
- 批准号:
10669091 - 财政年份:2021
- 资助金额:
$ 438.7万 - 项目类别:
COVID-19 Epidemiology and Immune-Pathogenesis in Pregnant Women, Mothers and Children
COVID-19 孕妇、母亲和儿童的流行病学和免疫发病机制
- 批准号:
10213945 - 财政年份:2020
- 资助金额:
$ 438.7万 - 项目类别:
Impact of the Initial Influenza Exposure on the Quality, Magnitude, Breadth, Potency and Durability of Influenza Immunity
初次接触流感对流感免疫的质量、程度、广度、效力和持久性的影响
- 批准号:
10394227 - 财政年份:2019
- 资助金额:
$ 438.7万 - 项目类别:
Impact of the Initial Influenza Exposure on the Quality, Magnitude, Breadth, Potency and Durability of Influenza Immunity
初次接触流感对流感免疫的质量、程度、广度、效力和持久性的影响
- 批准号:
10614959 - 财政年份:2019
- 资助金额:
$ 438.7万 - 项目类别:
COVID-19 Epidemiology and Immune-Pathogenesis in Pregnant Women, Mothers and Children
COVID-19 孕妇、母亲和儿童的流行病学和免疫发病机制
- 批准号:
10611603 - 财政年份:2019
- 资助金额:
$ 438.7万 - 项目类别:
COVID-19 Epidemiology and Immune-Pathogenesis in Pregnant Women, Mothers and Children
COVID-19 孕妇、母亲和儿童的流行病学和免疫发病机制
- 批准号:
10265666 - 财政年份:2019
- 资助金额:
$ 438.7万 - 项目类别:
Enhanced Surveillance for New Vaccine Preventable Diseases
加强对新疫苗可预防疾病的监测
- 批准号:
9206762 - 财政年份:2016
- 资助金额:
$ 438.7万 - 项目类别:
Enhanced Surveillance for New Vaccine Preventable Diseases
加强对新疫苗可预防疾病的监测
- 批准号:
9980742 - 财政年份:2016
- 资助金额:
$ 438.7万 - 项目类别:
相似海外基金
Rationally guided discovery platform for monoclonal antibodies against carbohydrate antigens using virus-like particle conjugate immunization and high throughput selection
使用病毒样颗粒缀合物免疫和高通量选择的合理引导的针对碳水化合物抗原的单克隆抗体的发现平台
- 批准号:
10574738 - 财政年份:2023
- 资助金额:
$ 438.7万 - 项目类别:
Assessing the role of liver stage antigens-specific antibodies against Plasmodium falciparum liver stage infection
评估肝期抗原特异性抗体对抗恶性疟原虫肝期感染的作用
- 批准号:
10392870 - 财政年份:2021
- 资助金额:
$ 438.7万 - 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
- 批准号:
10092930 - 财政年份:2020
- 资助金额:
$ 438.7万 - 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
- 批准号:
9896170 - 财政年份:2020
- 资助金额:
$ 438.7万 - 项目类别:
Interrogation of cell surface antigens on B lineage cells using structurally unique variable lymphocyte receptor antibodies of the evolutionarily distant sea lamprey
使用进化遥远的海七鳃鳗结构独特的可变淋巴细胞受体抗体询问 B 谱系细胞上的细胞表面抗原
- 批准号:
433456 - 财政年份:2020
- 资助金额:
$ 438.7万 - 项目类别:
Operating Grants
Investigations of interactions between various natural antibodies and food-derived antigens
研究各种天然抗体与食物源性抗原之间的相互作用
- 批准号:
19K15765 - 财政年份:2019
- 资助金额:
$ 438.7万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Identifying Kawasaki Disease-Specific Antibodies and Antigens
识别川崎病特异性抗体和抗原
- 批准号:
9932769 - 财政年份:2018
- 资助金额:
$ 438.7万 - 项目类别:
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
- 批准号:
BB/P504713/1 - 财政年份:2017
- 资助金额:
$ 438.7万 - 项目类别:
Training Grant
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
- 批准号:
1932904 - 财政年份:2017
- 资助金额:
$ 438.7万 - 项目类别:
Studentship
SBIR Phase II: Automated Design Methods of Antibodies Directed to Protein and Carbohydrate Antigens
SBIR II 期:针对蛋白质和碳水化合物抗原的抗体的自动化设计方法
- 批准号:
1632399 - 财政年份:2016
- 资助金额:
$ 438.7万 - 项目类别:
Standard Grant